Altruist Biologics Congratulates Partner LongBio Pharma on the BLA Acceptance of LP-003 by the China NMPA

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Altruist-LongBioPharm

More Like This

China's Leading Innovative Drug Developer for Allergic and Autoimmune Diseases LongBio Pharma Lists on Hong Kong Stock Exchange

PR Newswire associated0

Altruist Biologics' Hangzhou Facility Secures First Commercial Manufacturing License

PR Newswire associated0

Altruist Biologics Completes First Commercial PPQ Campaign of its 20,000L Production Line at the Hangzhou Site

PR Newswire associated0

Altruist Biologics' Hangzhou Antibody-Drug Conjugate Facility Receives Provincial Regulatory Approval for Segmented Production

PR Newswire associated0

Altruist Biologics Launches Altru-CON™ High-Concentration Formulation Platform to Accelerate Biologics Development

Business Wire logo

Biocytogen and Nanjing Chia Tai Tianqing Announce IND Approval in China for Co-Developed Anti-IGF-1R Antibody NTB003 (BCG009)

WuXi Biologics Announces Research Service Agreement with BioNTech on Discovering Investigational Monoclonal Antibodies for Developing Next-Generation Therapeutic Product Candidates

PR Newswire associated0

Rakuten Medical and LOTTE Biologics Sign Manufacturing Agreement to Support Biopharmaceuticals in Global Oncology Program